| 000 | 00699nam a22002057a 4500 | ||
|---|---|---|---|
| 008 | 121022b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 110 | _aAdvisory Council on the Misuse of Drugs [ACMD] | ||
| 245 | _aMethoxetamine [PDF] | ||
| 260 |
_aS.l. _bAdvisory Council on the Misuse of Drugs (ACMD) _c2012 |
||
| 300 | _a20 p. | ||
| 650 | _adrugs | ||
| 650 | _aproductinformatie | ||
| 650 | _aadviezen | ||
| 650 | _awetgeving | ||
| 650 | _aVerenigd Koninkrijk | ||
| 650 | _aonderzoeksrapporten | ||
| 856 | _uhttp://www.google.com/search?q=The-ACMD-considers-from-the-available-evidence-that-the-harms-of-methoxetamine-are-commensurate-with-Class-B home-office pdf | ||
| 999 |
_c16529 _d16529 |
||